Pembrolizumab 25 MG/ML [Keytruda]: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 3 1

Conditions being studied

Condition	Trials
Lung Cancer, Nonsmall Cell	1
Lung cancer	1

Recruiting trials involving Pembrolizumab 25 MG/ML [Keytruda]

A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
NCT05085028 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 37 locations

Common questions

How many recruiting trials involve Pembrolizumab 25 MG/ML [Keytruda]?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.